News
05-18-2010, 04:02 AM
Neoprobe Corporation, a diversified developer of innovative biomedical surgical oncology products, today announced that its gamma radiation detection system product line, which includes the neo2000® and neoprobe® GDS systems, was featured in a peer reviewed publication characterizing the emergence of the use of radioactive "seeds" to assist in the surgical excision of non-palpable breast lesions.
More... (http://www.news-medical.net/news/20100518/Neoprobe-gamma-radiation-detection-systems-featured-in-RSL-peer-review-in-American-Journal-of-Surgery.aspx)
More... (http://www.news-medical.net/news/20100518/Neoprobe-gamma-radiation-detection-systems-featured-in-RSL-peer-review-in-American-Journal-of-Surgery.aspx)